Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
ClinicalTrials.gov study NCT05714345. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
ClinicalTrials.gov study NCT05537766. IPD Sharing: NO. Countries: 8. Publications: 0.
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00054639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01003769. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT
ClinicalTrials.gov study NCT02692248. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of
ClinicalTrials.gov study NCT00850512. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00703664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06230224. IPD Sharing: YES. Countries: 16. Publications: 0.
A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies
ClinicalTrials.gov study NCT02651662. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas
ClinicalTrials.gov study NCT03218072. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
ClinicalTrials.gov study NCT01700946. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma
ClinicalTrials.gov study NCT05757700. IPD Sharing: YES. Countries: 1. Publications: 0.
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
ClinicalTrials.gov study NCT04599634. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT00254163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
ClinicalTrials.gov study NCT05211336. IPD Sharing: YES. Countries: 1. Publications: 0.
Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies
ClinicalTrials.gov study NCT02328014. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Inotuzumab and Blinatumomab in People With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07313852. IPD Sharing: YES. Countries: 1. Publications: 0.
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00816595. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05626322. IPD Sharing: YES. Countries: 3. Publications: 0.
TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03123393. IPD Sharing: YES. Countries: 6. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.